News Release

 

Back
 

AmerisourceBergen Elects Jane E. Henney, M.D. to Its Board of Directors

01/07/02
VALLEY FORGE, Pa., Jan 7, 2002 (BUSINESS WIRE) -- AmerisourceBergen Corporation (NYSE:ABC) today announced that Jane E. Henney, M.D., 54, has been elected to its Board of Directors.

The election expands the AmerisourceBergen board from eight to nine members.

Dr. Henney currently is Senior Scholar in Residence at the Association of Academic Health Centers in Washington, D.C. Prior to this appointment, she was Commissioner of the Food and Drug Administration (FDA) from 1998 through 2001. She was also Deputy Commissioner for Operations at the FDA from 1992 to 1994.

She is a medical oncologist and has held several posts at the National Cancer Institute, including Deputy Director from 1980 to 1995. Her past academic positions include Vice President for Health Sciences at the University of New Mexico and Vice Chancellor of Health Programs and Policy at the University of Kansas.

Dr. Henney is a frequent lecturer on a variety of healthcare subjects, and has received many honors and awards in her field.

Robert E. Martini, Chairman of the Board of Directors of AmerisourceBergen, said, "Dr. Henney brings considerable expertise and experience in healthcare. The Company and its shareholders are fortunate to have the multiple talents of Dr. Henney to help mold the future direction of AmerisourceBergen."

R. David Yost, AmerisourceBergen's President and Chief Executive Officer, added, "Dr. Henney will be a great addition to the Board. I look forward to working with her as we build AmerisourceBergen."

Dr. Henney received her Bachelor of Science degree from Manchester College, North Manchester, Indiana, and her Doctor of Medicine degree from Indiana University School of Medicine. Her graduate medical education includes a Fellowship in Medical Oncology at the Department of Developmental Therapeutics at M.D. Anderson Hospital and Tumor Institute in Houston, Texas.

    About AmerisourceBergen
AmerisourceBergen (NYSE:ABC) is the largest pharmaceutical services company in the United States dedicated solely to the pharmaceutical supply chain. It is the leading distributor of pharmaceutical products and services to the hospital systems/acute care market, alternative care providers, independent community pharmacies, and regional chains.

The company is also a leader in the institutional pharmacy marketplace. With approximately $35 billion in annualized operating revenues, AmerisourceBergen is headquartered in Valley Forge, PA, and employs more than 13,000 people serving over 25,000 customers.

CONTACT:          AmerisourceBergen
                  Michael N. Kilpatric, 610/727-7118
                  mkilpatric@amerisource.com

Corporate Overview

AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel..

Learn More